Conference Report

Coverage of the 2006 Annual Meeting of the Infectious Disease Society of America

Source: CCO Independent Conference Coverage of the 2006 Annual Meeting of the Infectious Disease Society of America*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Coverage of the 2006 Annual Meeting of the Infectious Disease Society of America


Faculty:

Joseph J. Eron, Jr., MDKimberly Y. Smith, MD, MPH
  • Joseph J. Eron, Jr., MD
  • Kimberly Y. Smith, MD, MPH

CME CREDIT INFORMATION

Release Date: 12/13/06

Expiration Date: 12/12/07


Physicians: maximum of 1.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Begin the Conference Report

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe various strategies for the treatment of HIV and clinical markers of treatment failure in HIV patients
  • Recount data on the safety and efficacy of darunavir as therapy for treatment-experienced HIV patients
  • Discuss the effect of HAART on mortality in HIV-infected patients

Topics covered include:

  • Introduction
  • Impact of Treating Herpes Simplex Virus 2 on HIV-1 RNA
  • Antiretroviral Therapy Within the First Year Following Diagnosis
  • Association of Baseline Proportions of X4 HIV-1 With Subsequent Disease Progression
  • Frequency of Primary Resistance in Patients From a St Louis, Missouri–Based Clinic
  • Long-term Outcomes of Directly Observed Antiretroviral Therapy in a Methadone Clinic
  • Efficacy Analyses and Safety Reports on Darunavir/Ritonavir From the POWER 1, 2, and 3 Trials
  • Once-Daily Administration of Enfuvirtide
  • Drug-Drug Interactions: Etravirine and Rifabutin
  • Frequency of Bone Density Loss in Hypogonadal in Men Infected With HIV
  • Survival Rates in Patient Cohorts Spanning 3 HAART Treatment Eras
  • WIHS Cohort: Causes of Death Among HIV-Infected Women From 1994-2004
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.